New potential treatment for prostate cancer

New hope for treating reduced exercise capacity caused by heart failure

Smart needle senses tissue pressure to detect its location

Fast, flexible ionic transistors for bioelectronic devices

A team led by Dion Khodagholy, assistant professor of electrical engineering at Columbia Engineering, and Jennifer N. Gelinas, Columbia University Medical Center, Department of Neurology, and the Institute for Genomic Medicine, has developed the first biocompatible ion-driven transistor that is fast enough to enable real-time signal sensing and stimulation of brain signals.

by
18 days ago

Mobile bedside bioprinter can heal wounds

Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have created a mobile skin bioprinting system – the first of its kind – that allows bi-layered skin to be printed directly into a wound. According to Sean Murphy, PhD, a WFIRM assistant professor who was lead author of the study, the unique aspect of this technology is the mobility of the system and the ability to provide on-site management of extensive wounds by scanning and measuring them in order to deposit the cells directly where they are needed to create skin.

by
19 days ago

Huge genome reveals stability genes tied to cancer protection

A team led by scientists from Nova Southeastern University’s (NSU) Save Our Seas Foundation Shark Research Center and Guy Harvey Research Institute (GHRI), Cornell University College of Veterinary Medicine, and Monterey Bay Aquarium, completed the white shark genome and compared it to genomes from a variety of other vertebrates, including the giant whale shark and humans.The great white shark is one of the most recognized marine creatures on Earth, generating widespread public fascination and media attention, including spawning one of the most successful movies in Hollywood history. This shark possesses notable characteristics, including its massive size (up to 20 feet and 7,000 pounds) and diving to nearly 4,000 foot depths. Great whites are also a big conservation concern given their relatively low numbers in the world’s oceans.

by
21 days ago

World’s first gene therapy operation for common cause of sight loss

Nano-shells deliver molecules that tell bone to repair itself

New microfluidics device can detect cancer cells in blood

Typhoid vaccine may protect against other infections

New research by the University of Liverpool (UOL) and Liverpool School of Tropical Medicine shows that vaccination with weakened strains of Salmonella may also protect against other infections. The researchers hope that the findings could impact vaccination strategy in the developing world, where infectious diseases are common and where broader protection could potentially save many lives. Typhoid fever (lat. typhoidearun febricitantem) is a bacterial bloodstream infection caused by Salmonella Typhi that is estimated to affect between 11-18 million people and cause between than 128,000-190,000 deaths annually worldwide.

by
23 days ago

Scientists turn carbon dioxide back into coal

Researchers have used liquid metals to turn carbon dioxide back into solid coal, in a world-first breakthrough that could transform the approach to carbon capture and storage. The research team led by RMIT University in Melbourne, Australia, have developed a new technique that can efficiently convert CO2 from a gas into solid particles of carbon. Current technologies for carbon capture and storage focus on compressing CO2 into a liquid form, transporting it to a suitable site and injecting it underground. But implementation has been hampered by engineering challenges, issues around economic viability and environmental concerns about possible leaks from the storage sites.

by
23 days ago

Technology for restoring brain cells damaged in Parkinson's

The multimillion-pound study, funded by Parkinson's UK with support from the Cure Parkinson's Trust and in association with the North Bristol NHS Trust and the University of Bristol (UniBristol), aimed to investigate whether boosting the levels of a naturally-occurring protein, Glial Cell Line-Derived Neurotrophic Factor (GDNF), can regenerate dying brain cells in people with Parkinson’s (lat. Parkinson scriptor morbus) and reverse their condition, which is something that no existing treatment can do.

by
23 days ago

Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.

I AGREE

THE MOST ADVANCED SCIENCE SPINOFF SCOUTING SYSTEM